Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Talon Therapeutics and FDA reach agreement on HALLMARQ trial

Aug. 30, 2011

Boehringer Ingelheim begins new afatinib trials in breast cancer

Aug. 30, 2011

Hanmi Holdings presents new epidermal growth factor receptor inhibitors

Aug. 30, 2011

FDA approves Xalkori and companion diagnostic kit

Aug. 29, 2011

Mologen reports results from phase I/II renal cancer trial

Aug. 29, 2011

Nerviano Medical Sciences discloses new B-raf inhibitors

Aug. 29, 2011

BioTime subsidiary receives funding to expand development of cancer diagnostics and therapeutics

Aug. 26, 2011

Korean company prepares novel inducers of apoptosis

Aug. 26, 2011

CSIR claims novel anticancer artemisinin derivatives

Aug. 26, 2011

New DNA replication and repair protein inhibitors presented by STC.UNM

Aug. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...